Liver and intrahepatic bile duct neoplasm
MONDO:0024477A benign or malignant neoplasm that affects the liver parenchyma or intrahepatic bile ducts. Representative examples of benign neoplasms include hepatocellular adenoma, and bile duct adenoma. Representative examples of malignant neoplasms include hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and lymphoma.
Also known as: epithelial hepatic and intrahepatic bile duct neoplasm, hepatic and intrahepatic bile duct neoplasm, liver and intrahepatic bile duct epithelial neoplasm, liver and intrahepatic bile duct neoplasm, liver neoplasm, liver neoplasm (disease), liver tumor, liver tumour
3102 clinical trials for this condition and its sub-types, 78 tagged with Liver and intrahepatic bile duct neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Liver and intrahepatic bile duct neoplasm
-
Liver cancer 255 trials · 1,708 incl. sub-types
5 sub-types
- Carcinoma of liver and intrahepatic biliary tract 36 trials · 1,461 incl. sub-types Sub-types →
- Biliary tract cancer 244 trials · 618 incl. sub-types Sub-types →
- Liver sarcoma 1 trial · 10 incl. sub-types Sub-types →
- Liver lymphoma 1 trial Sub-types →
- Calcifying nested epithelial stromal tumor of the liver 0 trials
-
Biliary tract neoplasm 31 trials · 627 incl. sub-types
2 sub-types
- Biliary tract cancer 244 trials · 618 incl. sub-types Sub-types →
- Bile duct neoplasm 41 trials · 472 incl. sub-types Sub-types →
-
Liver hemangioma 6 trials
1 sub-type
- Liver cavernous hemangioma 0 trials
-
Hepatocellular adenoma 2 trials
1 sub-type
- Hepatic adenomas, familial 0 trials
-
Hepatic angiomyolipoma 0 trials
-
Hepatic granuloma 0 trials
-
Liver adenomatosis 0 trials
-
Liver leiomyoma 0 trials
1 sub-type
- Extrahepatic bile duct leiomyoma 0 trials
-
Liver lipoma 0 trials
1 sub-type
- Extrahepatic bile duct lipoma 0 trials
-
Liver mesenchymal hamartoma 0 trials
-
Liver solitary fibrous tumor 0 trials
Most studied deeper sub-types
-
Experimental immune cell therapy for liver cancer hits early roadblock
Disease control Stopped earlyThis early-stage trial tested a new type of immune cell therapy (ET140203 T cells) in 8 adults with advanced liver cancer that had not responded to other treatments. The therapy was designed to target a protein called AFP found on cancer cells. The study was terminated early, so …
Phase 1 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:13 UTC
-
GPS and glowing dye aim to make liver biopsies more accurate
Diagnosis Stopped earlyThis study tested a new method to improve liver biopsies for people with suspected liver cancer. It combined a GPS-like tracking system with a special dye (ICG) that makes cancer cells glow. Seven adults participated, and the goal was to see if this combination could help doctors…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
New registry aims to sharpen liver tumor ablation techniques
Knowledge-focused Stopped earlyThis study tracked over 1,200 people with liver cancer who received microwave ablation, a procedure that uses heat to destroy tumors. Researchers collected data over 5 years to see how well the ablation worked and how long patients lived. The goal was to create better guidelines …
Sponsor: Ethicon, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC